← Leaderboards
Sheila A Stewart
Whitehead Institute For Biomedical Res
$11,336,646
Attributed
$11,602,646
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,102,645 · 16
By mechanism
R01$10,251,141 · 8
U54$7,499,999 · 1
R56$920,750 · 2
R21$344,250 · 1
F32$61,990 · 1
P41$24,515 · 3
Top collaborators
- Feng Chen5 shared
- Li Ding5 shared
- Ryan C Fields5 shared
- Susan E Mackinnon1 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsSenescencePhenotypePlayAgingMalignant NeoplasmsTumorCell GrowthNeoplastic CellTissuesCell AgingHuman TissueStromal CellsTumorigenesisImmune SystemMutationInvestigationComplexTumor GrowthFibroblastsRisk FactorsEnvironmentMolecularAge Related
Grant awards (42)
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,500,000
U54 · FY2025 · AG
Senescent stromal cells drive chemotherapy-induced peripheral neuropathy$589,106
R01 · FY2025 · AG · contact PI
Senescent CAFs in Breast Cancer Progression$576,723
R01 · FY2025 · AG · contact PI
Leveraging the metastatic tumor stroma to limit breast cancer progression$462,667
R01 · FY2025 · CA · contact PI
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,500,000
U54 · FY2024 · AG
Leveraging the metastatic tumor stroma to limit breast cancer progression$458,795
R01 · FY2024 · CA · contact PI
Senescent CAFs in Breast Cancer Progression$388,750
R56 · FY2024 · AG · contact PI
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,500,000
U54 · FY2023 · AG
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,499,999
U54 · FY2022 · AG
MICROENVIRONMENTAL CONTROLS OF TUMOR DORMANCY$496,988
R01 · FY2022 · AG · contact PI
SENESCENT STROMA STIMULATES INFLAMMATION TO PROMOTE TUMORIGENESIS$350,032
R01 · FY2022 · CA · contact PI
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,500,000
U54 · FY2021 · AG
MICROENVIRONMENTAL CONTROLS OF TUMOR DORMANCY$506,748
R01 · FY2021 · AG · contact PI
SENESCENT STROMA STIMULATES INFLAMMATION TO PROMOTE TUMORIGENESIS$357,176
R01 · FY2021 · CA · contact PI
MICROENVIRONMENTAL CONTROLS OF TUMOR DORMANCY$503,927
R01 · FY2020 · AG · contact PI
SENESCENT STROMA STIMULATES INFLAMMATION TO PROMOTE TUMORIGENESIS$357,176
R01 · FY2020 · CA · contact PI
MICROENVIRONMENTAL CONTROLS OF TUMOR DORMANCY$501,578
R01 · FY2019 · AG · contact PI
SENESCENT STROMA STIMULATES INFLAMMATION TO PROMOTE TUMORIGENESIS$346,461
R01 · FY2019 · CA · contact PI
MICROENVIRONMENTAL CONTROLS OF TUMOR DORMANCY$496,208
R01 · FY2018 · AG · contact PI
SENESCENT STROMA STIMULATES INFLAMMATION TO PROMOTE TUMORIGENESIS$357,176
R01 · FY2018 · CA · contact PI
Uncovering the Mechanisms by which Aged Stroma Impacts Tumor Initiation$315,400
R01 · FY2015 · CA · contact PI
Uncovering the Mechanisms by which Aged Stroma Impacts Tumor Initiation$305,938
R01 · FY2014 · CA · contact PI
HDNA2 IN DNA REPLICATION AND TELOMERE STABILITY$288,800
R01 · FY2014 · GM · contact PI
Uncovering the Mechanisms by which Aged Stroma Impacts Tumor Initiation$296,476
R01 · FY2013 · CA · contact PI
HDNA2 IN DNA REPLICATION AND TELOMERE STABILITY$273,734
R01 · FY2013 · GM · contact PI
THE ROLE OF FIBROBLAST-DERIVED OSTEOPONTIN IN TUMORIGENESIS$230,065
R01 · FY2013 · CA · contact PI
NERVE ALLOTRANSPLANTATION FOR TRAUMATIC NERVE INJURY$532,000
R56 · FY2012 · NS
Uncovering the Mechanisms by which Aged Stroma Impacts Tumor Initiation$311,084
R01 · FY2012 · CA · contact PI
HDNA2 IN DNA REPLICATION AND TELOMERE STABILITY$286,034
R01 · FY2012 · GM · contact PI
THE ROLE OF FIBROBLAST-DERIVED OSTEOPONTIN IN TUMORIGENESIS$244,750
R01 · FY2012 · CA · contact PI
Uncovering the Mechanisms by which Aged Stroma Impacts Tumor Initiation$309,789
R01 · FY2011 · CA · contact PI
HDNA2 IN DNA REPLICATION AND TELOMERE STABILITY$278,920
R01 · FY2011 · GM · contact PI
THE ROLE OF FIBROBLAST-DERIVED OSTEOPONTIN IN TUMORIGENESIS$244,750
R01 · FY2011 · CA · contact PI
TELOMERE BINDING PROTEINS AND CELLULAR AGING$6,075
P41 · FY2011 · RR · contact PI
THE ROLE OF FIBROBLAST-DERIVED OSTEOPONTIN IN TUMORIGENESIS$252,320
R01 · FY2010 · CA · contact PI
TELOMERE BINDING PROTEINS AND CELLULAR AGING$9,710
P41 · FY2010 · RR · contact PI
THE ROLE OF FIBROBLAST-DERIVED OSTEOPONTIN IN TUMORIGENESIS$252,320
R01 · FY2009 · CA · contact PI
TELOMERE BINDING PROTEINS AND CELLULAR AGING$8,730
P41 · FY2009 · RR · contact PI
Cellular Lifespan and the Telomere Proteome$153,000
R21 · FY2005 · AG
Cellular Lifespan and the Telomere Proteome$191,250
R21 · FY2004 · AG
Molecular Mechanisms of Cellular Immortality$18,218
F32 · FY2003 · CA
Molecular Mechanisms of Cellular Immortality$43,772
F32 · FY2001 · CA